PEAK6 Investments’s Progyny PGNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-25,200
Closed -$809K 4510
2023
Q1
$809K Buy
25,200
+7,700
+44% +$254K ﹤0.01% 2003
2022
Q4
$545K Buy
17,500
+11,400
+187% +$412K ﹤0.01% 2440
2022
Q3
$226K Sell
6,100
-1,200
-16% -$44.9K ﹤0.01% 3569
2022
Q2
$212K Buy
7,300
+5,800
+387% +$208K ﹤0.01% 4711
2022
Q1
$77K Buy
+1,500
New +$64.2K ﹤0.01% 4412
2021
Q4
Sell
-7,300
Closed -$409K 5647
2021
Q3
$409K Sell
7,300
-22,700
-76% -$1.25M ﹤0.01% 3417
2021
Q2
$1.77M Buy
+30,000
New +$1.69M ﹤0.01% 2012

Other funds holding PGNY

PEAK6 Investments's PGNY Position: Q3 2024 in Review

PEAK6 Investments reduced its Progyny (PGNY) stake by 6.6% in Q3 2024, selling an estimated $17.5K and leaving 10,273 shares worth $172K. The position accounts for ﹤0.01% of the portfolio, ranked #2829.

PEAK6 Investments first reported a position in PGNY in Q4 2020 and has held it in 11 quarters since. The position peaked at $2.31M in Q2 2021. 285 funds tracked by Wall St. Rank hold PGNY as of Q3 2024.

  • PEAK6 Investments held 10,273 shares of Progyny worth $172K as of Q3 2024.
  • PEAK6 Investments sold 728 Progyny shares in Q3 2024, an estimated $17.5K.
  • Progyny made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #2829 holding.
  • PEAK6 Investments first reported a position in Progyny in Q4 2020 and has held it in 11 quarters since.
  • PEAK6 Investments's Progyny position peaked at $2.31M in Q2 2021.
  • 285 funds tracked by Wall St. Rank held Progyny as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.